bioMérieux

(OTC) BMXMF

Current Price$77.93

Market Cap$9.19B

Since IPO (2004)+115%

5 Year-32%

1 Year-45%

1 Month-6%

bioMérieux Financials at a Glance

Market Cap

$9.19B

Revenue (TTM)

€8.05B

Net Income (TTM)

€829.41M

EPS (TTM)

$3.80

P/E Ratio

20.36

Dividend

$1.13

Beta (Volatility)

0.26 (Low)

Dividend

$1.13

Beta (Volatility)

0.26 (Low)

Price

$77.93

Volume

153

Open

$78.26

Price

$77.93

Volume

153

Open

$78.26

Previous Close

$77.93

Daily Range

$77.93 - $78.26

52-Week Range

$77.00 - $152.00

Estimated Earnings Date

Jul 28, 2026

Dividend

$1.13

Beta (Volatility)

0.26 (Low)

Price

$77.93

Volume

153

Open

$78.26

Previous Close

$77.93

Daily Range

$77.93 - $78.26

52-Week Range

$77.00 - $152.00

Estimated Earnings Date

Jul 28, 2026

BMXMF News

No articles available.

Motley Fool Moneyball Superscore

Our CEO Is Handing Members His Secret Weapon

It's called Motley Fool Moneyball, our new proprietary AI tool

We spent over half a million dollars in R&D to build a tool that makes stock research faster, sharper, and smarter. Our analysts use it every day, and now, you can too.

Get Access Now

About bioMérieux

Industry

Healthcare Equipment and Supplies

Sector

Health Care

Employees

15,078

CEO

Pierre Boulud

Website

www.biomerieux.com

Headquarters

Marcy l'Étoile, 69280, FR

BMXMF Financials

Key Financial Metrics (TTM)

Gross Margin

53.07%

Operating Margin

9.54%

Net Income Margin

9.76%

Return on Equity

9.89%

Return on Capital

14.35%

Return on Assets

7.13%

Earnings Yield

4.91%

Dividend Yield

1.45%

Payout Ratio

26.71%

Stock Overview

Market Cap

$9.19B

Shares Outstanding

117.99M

Volume

153

Avg. Volume

393.629

Financials (TTM)

Gross Profit

€4.37B

Operating Income

€977.03M

EBITDA

€1.85B

Operating Cash Flow

€1.46B

Capital Expenditure

-€681.03M

Free Cash Flow

€774.39M

Cash & ST Invst.

€569.59M

Total Debt

€461.23M

bioMérieux Performance Analysis

Revenue Growth Rate

Annual and quarterly growth comparison

Earnings Per Share Growth Rate

Annual and quarterly EPS growth comparison

Quarterly Performance

Name

Q4 2025YOY CHG

Revenue

€2.03B

+6.3%

Gross Profit

€992.43M

+2.2%

Gross Margin

49.00%

N/A

Market Cap

$9.19B

N/A

Market Cap/Employee

$649.95K

N/A

Employees

14,147

N/A

Net Income

€236.21M

+20.5%

EBITDA

€475.72M

-0.5%

Quarterly Fundamentals

Name

Q4 2025YOY CHG

Total Cash

€569.59M

+61.6%

Total Debt

€461.23M

-11.1%

Accounts Receivable

€1.01B

+38.7%

Inventory

€959.34M

+5.6%

Long Term Debt

€330.00M

-7.1%

Short Term Debt

€131.40M

-19.6%

Return on Assets

7.13%

N/A

Return on Invested Capital

8.61%

N/A

Free Cash Flow

€288.09M

+163.1%

Operating Cash Flow

€470.62M

+58.2%

Other Investments to Explore

People Also Watch

SymbolSymbol / CompanyCompanyPricePrice Chg

CRLCharles River Laboratories International, Inc.

CRLCharles River Laboratories International, Inc.$230.69+0.70%

TWSTTwist Bioscience Corporation

TWSTTwist Bioscience Corporation$99.24-2.94%

ICLRICON Public Limited Company

ICLRICON Public Limited Company$173.06-1.14%

CDNACareDx, Inc

CDNACareDx, Inc$29.19-0.21%

PREPrenetics Global Limited

PREPrenetics Global Limited$16.93-5.37%

FONRFonar Corp.

FONRFonar Corp.$19.09+0.00%

STIMNeuronetics, Inc.

STIMNeuronetics, Inc.$1.41+4.44%

Trending Stocks

SymbolSymbol / CompanyCompanyPricePrice Chg

AALAmerican Airlines Group

AALAmerican Airlines Group$17.92-0.01%

TSLLDirexion Shares ETF Trust - Direxion Daily Tsla Bull 2x Shares

TSLLDirexion Shares ETF Trust - Direxion Daily Tsla Bull 2x Shares$12.30-0.15%

CLROClearOne

CLROClearOne$6.48+1.01%

TQQQProShares Trust - ProShares UltraPro Qqq

TQQQProShares Trust - ProShares UltraPro Qqq$73.35-0.05%

ONDSOndas

ONDSOndas$7.41-0.06%

SOFISoFi Technologies

SOFISoFi Technologies$18.24-0.01%

NOKNokia

NOKNokia$12.07-0.07%

Questions About BMXMF

What is the current price of bioMérieux?

bioMérieux is trading at $77.93 per share.

What is the 52-week range for bioMérieux?

Over the past 52 weeks, bioMérieux has traded between $77.00 and $152.00.

How much debt does bioMérieux have?

As of the most recent reporting period, bioMérieux reported total debt of €541.89M.

How much cash does bioMérieux have on hand?

bioMérieux reported €669.20M in cash and cash equivalents in its most recent financial results.

What is bioMérieux’s dividend yield?

bioMérieux currently has a dividend yield of 1.45%.

bioMérieux

bioMérieux Financials at a Glance

BMXMF News

Motley Fool Moneyball Superscore

Our CEO Is Handing Members His Secret Weapon

About bioMérieux

BMXMF Financials

Key Financial Metrics (TTM)

Stock Overview

Financials (TTM)

bioMérieux Performance Analysis

Revenue Growth Rate

Earnings Per Share Growth Rate

Quarterly Performance

Quarterly Fundamentals

Other Investments to Explore

People Also Watch

Trending Stocks

Questions About BMXMF

What is the current price of bioMérieux?

What is the 52-week range for bioMérieux?

How much debt does bioMérieux have?

How much cash does bioMérieux have on hand?

What is bioMérieux’s dividend yield?

Premium Investing Services